Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 | ||
Di | Amkor Technology Stock Clears Key Benchmark, Hitting 80-Plus RS Rating | ||
Di | Dexcom Stock Continues To Post Very Healthy Profits, Returns | ||
Di | How To Get A 28% Return On Risk In Just Over Two Weeks On Applied Materials Stock | ||
Di | IBD Live Q&A And Two Key Stock Lists For April 30, 2024 | ||
Di | Tesla Rivals Li Auto, Nio, XPeng, BYD Set To Report April Sales Amid Price War | ||
Di | IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views | ||
Di | Breakout Watch: Nvidia, Broadcom Lead Top Stocks Setting Up | ||
Di | Nvidia Rises After 75% Gain As Earnings Loom; Is The Stock A Buy Now? | ||
Di | Stocks Retreat With Dow Hit Hardest; Tesla Drops As Executives Get Sacked | ||
Di | This Managed Care Leader Sets Up A New Buy Point Heading Into Earnings | ||
Di | Is Google A Buy Amid Q1 Earnings Beat, Artificial Intelligence Spending War? | ||
Di | PC Peripherals Maker Logitech Returns To Growth With March-Quarter Beat | ||
Di | Tenet Healthcare Earnings Surge 126% As Hospital Operator Now Expects Record Annual EPS | ||
Di | Elon Musk Reportedly Back In Layoff Mode After 10% Workforce Cuts Earlier This Month | ||
Di | Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC? | ||
Di | Is It Time To Buy XOM Stock As Shares Try To Recover From Earnings Drop? | ||
Di | As Google Rallies, Here Is What Analysts Expect From It And Nvidia | ||
Di | Elon Musk Reportedly Back In Lay Off Mode After 10% Workforce Cuts Earlier This Month | ||
Di | Dow Jones Futures Fall Ahead Of Fed Meeting; Tesla Slides On New Layoffs | ||
Di | PayPal Earnings Pop 27% Under New Reporting Method. PayPal Stock Is Set To Break Out. | ||
Di | Four Stocks Turn $10,000 Into $26,406 In 4 Months | ||
Di | How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits? | ||
Di | Dow Jones Notebook: McDonald's, Coca-Cola Trade Lower; 3M Poised For Breakout | ||
Di | Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat |